On Tuesday, Elevance Health Inc (NYSE: ELV) was -0.88% drop from the session before settling in for the closing price of $427.23. A 52-week range for ELV has been $362.21 – $567.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.25%. When this article was written, the company’s average yearly earnings per share was at 4.44%. With a float of $226.90 million, this company’s outstanding shares have now reached $227.48 million.
The extent of productivity of a business whose workforce counts for 104200 workers is very important to gauge. In terms of profitability, gross margin is 46.8%, operating margin of 4.49%, and the pretax margin is 4.47%.
Elevance Health Inc (ELV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Elevance Health Inc stocks. The insider ownership of Elevance Health Inc is 0.20%, while institutional ownership is 92.84%. The most recent insider transaction that took place on Mar 10 ’25, was worth 183,903. In this transaction CAO & Controller of this company sold 443 shares at a rate of $415.13, taking the stock ownership to the 1,847 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Officer proposed sale 443 for $415.13, making the entire transaction worth $183,904.
Elevance Health Inc (ELV) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 10.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.75% during the next five years compared to 6.81% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
You can see what Elevance Health Inc (ELV) is doing with its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.54. Likewise, its price to free cash flow for the trailing twelve months is 21.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 25.61, a number that is poised to hit 10.86 in the next quarter and is forecasted to reach 39.10 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
The latest stats from [Elevance Health Inc, ELV] show that its last 5-days average volume of 1.6 million was inferior to 1.66 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 55.45%. Additionally, its Average True Range was 10.24.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 80.68%, which indicates a significant increase from 67.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.39% in the past 14 days, which was lower than the 24.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $401.89, while its 200-day Moving Average is $459.53. Now, the first resistance to watch is $428.44. This is followed by the second major resistance level at $433.40. The third major resistance level sits at $437.86. If the price goes on to break the first support level at $419.02, it is likely to go to the next support level at $414.56. The third support level lies at $409.60 if the price breaches the second support level.
Elevance Health Inc (NYSE: ELV) Key Stats
There are 227,352K outstanding shares of the company, which has a market capitalization of 96.28 billion. As of now, sales total 177,011 M while income totals 5,980 M. Its latest quarter income was 45,442 M while its last quarter net income were 418,000 K.
